Início › Câncer de Pâncreas › Carolina do Norte
Ensaios clínicos de Câncer de Pâncreas em Carolina do Norte
34 estudos para Câncer de Pâncreas estão buscando participantes em locais em Carolina do Norte.
Cidades em Carolina do Norte
Texto oficial do estudo (Inglês)
The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
RecrutandoVoluntários saudáveis bem-vindos
Idades de 45 a 75 · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06995898Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- FirstHealth of the Carolinas, Pinehurst
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07562152Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Duke Cancer Center, Durham
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07621718DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- University of North Carolina Hospitals at Hillsborough, Hillsborough
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Duke Cancer Center, Durham
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07252232A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US035, Chapel Hill
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07522073Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Duke University Medical Center, Durham
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06445062A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0100, Durham
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07492680Promoting CT Engagement for Pancreatic Cancer With App
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06252545Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
- East Carolina University, Greenville
- e mais 1
RecrutandoEstudo observacional
Idades de 50 a 75 · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- University of North Carolina, Chapel Hill
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07644559Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill
- University of North Carolina, Chapel Hill
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT05245500Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06958328Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 1
Idades de 18 a 99 · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT03454035A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06751329Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
- Levine Cancer Institute, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jul. de 2026 · NCT05376592Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Duke University Medical Center, Durham
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT06937177Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Duke Cancer Institute /ID# 276267, Durham
- Carolina BioOncology Institute /ID# 232597, Huntersville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT05005403A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT06835569Autologous CAR-T Cells Targeting B7-H3 in PDAC
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT06158139Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT06040541Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- Southeastern Medical Oncology Center-Jacksonville, Jacksonville
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT06998940Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT06483555Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Carolina BioOncology Institute, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de fev. de 2026 · NCT07030257A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Charlotte
- Ohio State University-Telemedicine, Raleigh
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de fev. de 2026 · NCT06906562Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 2
Idades de 18 a 99 · Todos os sexos · Atualizado em 13 de jan. de 2026 · NCT03977233SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Levine Cancer Institute, Charlotte
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de ago. de 2025 · NCT04429542APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of North Carolina, Chapel Hill
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 27 de jun. de 2025 · NCT03175224Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de mar. de 2025 · NCT05776524Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.